Krystal Biotech Inc (NAS:KRYS)
$ 156.49 -6.34 (-3.89%) Market Cap: 4.47 Bil Enterprise Value: 4.12 Bil PE Ratio: 83.24 PB Ratio: 5.58 GF Score: 36/100

Krystal Biotech Inc Annual Shareholders Meeting Transcript

May 29, 2020 / 05:00PM GMT
Release Date Price: $51.41 (+2.06%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Krystal Biotech Annual Shareholder Meeting. At this time, the meeting will begin.

It is now my pleasure to turn the floor over to your host, Krish Krishnan. Sir, the floor is yours.

Krish S. Krishnan
Krystal Biotech, Inc. - Chairman, President & CEO

Thank you. Good afternoon. I'm Krish Krishnan, Chief Executive Officer and Chairman of the Board of Directors of Krystal Biotech, and it's my pleasure to welcome you to our 2020 Annual Meeting of Shareholders. We're glad you're joining us today for our first virtual shareholders meeting, and we appreciate your continued support of Krystal.

I'll start the business of this meeting by introducing Chris Naftzger, our Chief Legal Officer, who will serve as secretary of this meeting.

Now I want to take a moment to recognize our Board members who may be listening into this meeting: Dan Janney, our lead independent Director; Dino Rossi; Julian Gangoli; Kirti Ganorkar; and Suma Krishnan. I also want to recognize the many contributions

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot